Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  OpGen, Inc.    OPGN

OPGEN, INC.

(OPGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société OPGEN, INC.
03:30pOPGEN : Corporate Presentation (PDF)
PU
10/15OPGEN INC : Results of Operations and Financial Condition (form 8-K)
AQ
10/15OPGEN : Provides Business and Pipeline Update and Announces Preliminary Unaudite..
AQ
10/15OpGen Provides Business and Pipeline Update and Announces Preliminary Unaudit..
GL
10/13OPGEN : Issues Formal Response to FDA's Requests for Additional Information and ..
AQ
10/13OpGen Issues Formal Response to FDA's Requests for Additional Information and..
GL
10/06OPGEN : Corporate Presentation (PDF)
PU
10/05OpGen Group Company Ares Genetics Wins Austrian Digitization Award for ares-g..
GL
10/05OPGEN : Ares Genetics Wins Austrian Digitization Award for ares-genetics.cloud
AQ
10/02OPGEN INC : Change in Directors or Principal Officers, Submission of Matters to ..
AQ
09/30OPGEN : Announces Award of German Government Grant Funding to its Subsidiary Cur..
AQ
09/30OpGen Announces Award of German Government Grant Funding to its Subsidiary Cu..
GL
09/28OPGEN : Announces Successful Completion of Study Collaboration with Karolinska I..
AQ
09/28OpGen Announces Successful Completion of Study Collaboration with Karolinska ..
GL
09/18OPGEN : Announces Notice of Annual Meeting Venue Change
AQ
09/18OpGen, Inc. Announces Notice of Annual Meeting Venue Change
GL
09/16OPGEN : Collaborative Research by OpGen Group Company Ares Genetics and Johns Ho..
AQ
09/16Collaborative Research by OpGen Group Company Ares Genetics and Johns Hopkins..
GL
09/14OPGEN : Corporate Presentation (PDF)
PU
09/08OPGEN : Ares Genetics Nominated for Austrian Innovation Award for AI-powered Mol..
AQ
09/08OpGen Group Company Ares Genetics Nominated for Austrian Innovation Award for..
GL
09/02Key Publication of Clinical Study Demonstrates Unyvero Lower Respiratory Trac..
GL
08/20OPGEN INC : Regulation FD Disclosure, Other Events, Financial Statements and Exh..
AQ
08/20OPGEN : Corporate Presentation (PDF)
PU
08/20OpGen Announces CE-IVD Marking and Commercial Launch in Europe of its Own Dev..
GL
08/12OPGEN : Other Events (form 8-K/A)
AQ
08/12OpGen Reports Second Quarter 2020 Financial Results and Provides Business Upd..
GL
08/11OPGEN INC : Change in Directors or Principal Officers, Amendments to Articles of..
AQ
08/11OpGen Group Company Ares Genetics Demonstrates Feasibility of CLIA-compliant ..
GL
08/10OPGEN INC : Results of Operations and Financial Condition (form 8-K)
AQ
08/09OpGen Co-Markets COVID-19 Antibody Test Kit
GL
08/05OpGen to Provide Business Update and Financial Results for the Second Quarter..
GL
07/15OPGEN INC : Results of Operations and Financial Condition (form 8-K)
AQ
07/15OpGen Provides Business Update and Announces Preliminary Unaudited Revenue an..
GL
07/14OPGEN INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
07/13OPGEN INC : Entry into a Material Definitive Agreement, Creation of a Direct Fin..
AQ
07/13Menarini Silicon Biosystems Partners with OpGen to Broaden Distribution of CE..
GL
07/09OPGEN : Subsidiary Curetis GmbH Secures Access to Additional EUR 5.0 Million Non..
AQ
07/07OPGEN : Corporate Presentation (PDF)
PU
06/15OPGEN : Financial Statements and Exhibits (form 8-K/A)
AQ
06/09OpGen Releases Preliminary Data Demonstrating its Unyvero HPN Panel for Pneum..
GL
06/03OPGEN INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
06/03OpGen Expands Partnership with New York State Department of Health and IDC to..
GL
05/11OPGEN INC : Other Events (form 8-K)
AQ
05/11OpGen CEO and Chairman of the Board Issue Letters to Stockholders
GL
05/08OPGEN : Note 2 - Liquidity and management's plans
AQ
05/07OPGEN INC : Results of Operations and Financial Condition, Change in Directors o..
AQ
05/07OpGen Reports First Quarter 2020 Financial Results and Provides Business Upda..
GL
04/28OPGEN INC : Entry into a Material Definitive Agreement, Creation of a Direct Fin..
AQ
04/27OpGen to Provide Business Update and Financial Results for the First Quarter ..
GL
04/21OpGen Subsidiary Curetis GmbH and Karolinska Institutet Collaborate in Study ..
GL
04/16OPGEN INC : Other Events (form 8-K)
AQ
04/16OpGen Subsidiary Ares Genetics Demonstrates Feasibility and Potential of Next..
GL
04/14OPGEN INC : Results of Operations and Financial Condition, Regulation FD Disclos..
AQ
04/14OpGen Announces Preliminary Unaudited Revenue and Cash Position for First Qua..
GL
04/02OPGEN INC : Completion of Acquisition or Disposition of Assets, Change in Direct..
AQ
04/01OpGen and Curetis Successfully Close their Business Combination Transaction
GL
03/30OPGEN INC : Submission of Matters to a Vote of Security Holders, Other Events (f..
AQ
03/30CURETIS N : OpGen Announces Shareholder Approval for Business Combination with C..
AQ
03/24OPGEN INC : Results of Operations and Financial Condition, Other Events, Financi..
AQ
03/24OpGen Reports Fourth Quarter and Full Year 2019 Financial Results and Provide..
GL
03/24OpGen Provides Further Update on Shareholder Proxy Voting in Relation to the ..
GL
03/24OPGEN : Management's Discussion and Analysis of Financial Condition and Results ..
AQ
03/23OpGen Data Predicting Phenotypic Antimicrobial Susceptibility Published in Di..
GL
03/19OPGEN INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
03/19OpGen Provides Update on Shareholder Proxy Voting in Relation to the Business..
GL
03/16OPGEN INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
03/16OpGen Provides Update on Curetis Now Offering BGI's CE-IVD Rapid Test Kit for..
GL
03/12OpGen to Provide Business Update and Financial Results for the Fourth Quarter..
GL
03/10OPGEN INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
03/10Curetis N.V. Shareholders Approve Planned Business Combination with OpGen
GL
02/28OPGEN INC : Entry into a Material Definitive Agreement, Financial Statements and..
AQ
02/20OPGEN INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
02/20OpGen Provides Update on Curetis Preliminary, Unaudited 2019 Condensed Combin..
GL
02/12OPGEN INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
1  2Next
Upcoming event on OPGEN, INC.